Which has grown faster, COO or IBRX?

Over the past five years, IBRX grew revenue faster — COO at a 8.29% CAGR versus IBRX at 202.97%.

Is COO or IBRX more profitable?

COO runs the higher net margin — COO at 13.46% versus IBRX at -598.56%.

How have COO and IBRX total returns compared?

Over the past 10 years, COO delivered 2.53% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.

The Cooper Companies, Inc. (COO) vs ImmunityBio, Inc. (IBRX)

A side-by-side comparison of The Cooper Companies, Inc. and ImmunityBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

COO

The Cooper Companies, Inc.

$10.98B

$56.30HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

IBRX

ImmunityBio, Inc.

$10.15B

$9.69HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — COO vs IBRX

growth of $100 · dividends reinvested · last 10y

COO +29.2% (+2.6%/yr)IBRX +41.8% (+3.6%/yr)IBRX compounded faster over this window

COO IBRX

COO vs IBRX: by the numbers

•COO is the larger company ($10.98B vs $10.15B market cap).
•COO is profitable (13.46% net margin) while IBRX runs a net loss (-598.56%).
•IBRX grew revenue faster over the past five years (202.97% vs 8.29% CAGR).

Metrics side by side

Valuation

Metric	COO	IBRX
P/E ratio	19.21	N/A
Forward P/E	12.39	N/A
P/S ratio	2.59	61.21
P/B ratio	1.32	N/A
EV / EBITDA	14.40	N/A
FCF yield	6.18%	N/A

Profitability

Metric	COO	IBRX
Gross margin	63.64%	94.63%
Operating margin	12.85%	-226.00%
Net margin	13.46%	-598.56%
ROE	6.85%	N/A
ROIC	4.76%	-45.63%

Growth (annualized)

Metric	COO	IBRX
Revenue CAGR (5Y)	8.29%	202.97%
EPS CAGR (5Y)	-17.30%	N/A
FCF CAGR (5Y)	5.21%	N/A
Total return CAGR (5Y)	-11.35%	0.39%

Frequently asked

Which has grown faster, COO or IBRX?: Over the past five years, IBRX grew revenue faster — COO at a 8.29% CAGR versus IBRX at 202.97%.
Is COO or IBRX more profitable?: COO runs the higher net margin — COO at 13.46% versus IBRX at -598.56%.
How have COO and IBRX total returns compared?: Over the past 10 years, COO delivered 2.53% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.

Go deeper

Full COO analysis Full IBRX analysis Interactive comparison tool

Dig into the metrics

Cooper Companies P/E ratio Cooper Companies ROE ImmunityBio ROE Cooper Companies operating margin ImmunityBio operating margin Cooper Companies revenue growth ImmunityBio revenue growth Cooper Companies free cash flow ImmunityBio free cash flow

Cooper Companies & ImmunityBio appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.